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Background: Allergen recognition by dendritic cells (DCs) is a key event in the allergic cascade leading to
production of IgE antibodies. C-type lectins, such as the mannose receptor and DC-SIGN, were recently shown to
play an important role in the uptake of the house dust mite glycoallergen Der p 1 by DCs. In addition to mannose
receptor (MR) and DC-SIGN the high and low affinity IgE receptors, namely FcεRI and FcεRII (CD23), respectively,
have been shown to be involved in allergen uptake and presentation by DCs.
Objectives: This study aims at understanding the extent to which IgE- and IgG-facilitated Der p 1 uptake by DCs
influence T cell polarisation and in particular potential bias in favour of Th2. We have addressed this issue by using
two chimaeric monoclonal antibodies produced in our laboratory and directed against a previously defined epitope
on Der p 1, namely human IgE 2C7 and IgG1 2C7.
Results: Flow cytometry was used to establish the expression patterns of IgE (FcεRI and FcεRII) and IgG (FcγRI)
receptors in relation to MR on DCs. The impact of FcεRI, FcεRII, FcγRI and mannose receptor mediated allergen
uptake on Th1/Th2 cell differentiation was investigated using DC/T cell co-culture experiments. Myeloid DCs
showed high levels of FcεRI and FcγRI expression, but low levels of CD23 and MR, and this has therefore enabled
us to assess the role of IgE and IgG-facilitated allergen presentation in T cell polarisation with minimal interference
by CD23 and MR. Our data demonstrate that DCs that have taken up Der p 1 via surface IgE support a Th2 response.
However, no such effect was demonstrable via surface IgG.
Conclusions: IgE bound to its high affinity receptor plays an important role in Der p 1 uptake and processing by
peripheral blood DCs and in Th2 polarisation of T cells.
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Allergic diseases represent a major health problem
affecting a large sector of the population [1,2]. Type I
hypersensitivity, or allergy, is initiated by the recognition
of an allergen by antigen presenting cells (mainly den-
dritic cells (DCs)), followed by a series of events that
eventually result in IgE antibody production, mast cell
sensitisation and triggering [3]. Allergen recognition
by DCs represents the first step in allergic sensitisation* Correspondence: amir.ghaemmaghami@nottingham.ac.uk
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reproduction in any medium, provided the orand, therefore, is considered an attractive target for
study since it might have an important role in deter-
mining subsequent downstream events of the allergic
cascade [4].
Allergens, such as Der p 1, that cause these allergic
reactions are generally innocuous proteins. Der p 1 is
considered as the most immunodominant allergen of the
house dust mite Dermatophagoides pteronyssinus [5]. It
is a 25 kDa protein with cysteine protease activity. This
protease activity is thought to be responsible for Der p 1
being a potent inducer of IgE synthesis, which is most
probably mediated by the cleavage of regulatory mole-
cules of IgE synthesis, such as CD23, CD25, CD40 andal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Time-related FcεRI, FcεRII, FcγRI and MR expressions.
Receptor expression was detected during the course of generating
DCs starting from day 0 (monocyte) through to days 2, 4, 6
(immature DC) and 8 (mature DC). The data presented show the
average of six independent experiments for FcεRI, CD23 and MR,
and three independent experiments for FcγRI, all expressed
as mean ± SEM.
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(ICAM3)-grabbing non-integrin (DC-SIGN or DC209) [6].
DCs are professional antigen-presenting cells that oc-
cupy a central position at the interface of innate immun-
ity and adaptive immune responses, through recognising
foreign antigens, processing them and presenting them
to T cell receptors via MHC molecules [7-9]. DCs use
multiple pathways and cell-surface molecules for antigen
capture and receptor-mediated endocytosis [10,11] which
could influence T cell polarisation.
In recent studies in our laboratory, it was shown that
the C-type lectin receptors, mannose receptor (CD206
or MR) and DC-SIGN, play a significant role in Der p 1
uptake, internalisation and presentation. It has been
shown that these receptors are characterised by the pres-
ence of carbohydrate recognition domains (CRD) that
recognise sugar moieties on allergens [12-15]. The other
two receptors thought to be involved in allergen uptake
by DCs are IgE high and low affinity receptors, FcεRI
and FcεRII (CD23) respectively. However, their precise
roles in capturing allergen by DCs and subsequent pres-
entation to T cells are not fully understood.
It has been previously suggested that IgE might play
an important role in antigen uptake by DCs through IgE
receptors [16]. It was also reported that the competence
of antigen uptake by Langerhans cells increases signifi-
cantly in the presence of IgE and its receptor [17]. In
this context, numerous studies by Maurer and co-
workers have emphasised the role of the high affinity IgE
receptor on DCs in the internalisation of IgE-bound
allergens and their presentation by the major histocom-
patibility complex (MHC) class II compartment in a
Cathepsin S-dependent pathway [18-20]. The low affin-
ity IgE receptor expressed by B cells was also shown to
participate in antigen presentation and activation of
T cells in a mouse model [21,22].
Together, these findings helped to formulate the hy-
pothesis of our work, which is that IgE-mediated aller-
gen presentation primes naïve T cells towards Th2 cell
differentiation. The elucidation of this mechanism could
clearly have therapeutic potential.
Previous work in our laboratory generated Der p
1-specific chimeric human IgE (IgE 2C7) and IgG (IgG1
2C7) antibodies consisting of mouse variable regions
(Vκ and VH) joined to a human IgE or IgG1 constant
regions, respectively [23,24]. It has been shown by
using phage peptide libraries that the Der p 1 epitope
targeted by 2C7 antibodies is Leu147-Gln160 [25], and
this specificity is representative of a major component
of the human IgE response to Der p 1 [23]. The
availability of these two antibodies has therefore
provided a unique opportunity to investigate the
consequences of IgE- versus IgG-facilitated Der p 1
presentation by DCs.Results
Time course expression of FcεRI, FcεRII (CD23), FcγRI and
MR by monocyte derived DCs (Mo-DCs)
The kinetics of expression of FcεRI, FcεRII (CD23),
FcγRI and mannose receptor were studied during the
course of generating Mo-DCs, starting from day zero
(monocyte) through to days 2, 4, 6 (immature) and 8
(mature).
FcεRI was modestly expressed on monocytes at day
zero, while FcεRII and MR were less well expressed
(Figure 1). On day two, FcεRI expression decreased, but
levels recovered on days 4 and 6. FcεRII and MR expres-
sions were at their maximum on days 2, 4 and 6 of cul-
ture (and day 8 in the case of MR). FcγRI expression
was high to start with (day 0) then levels diminished in
the course of generating the DCs.The specificity of IgE binding by Mo-DCs
Immature DCs (day 6 of culture) were stained with IgE-
FITC, in the presence or absence of unlabelled IgE or
IgG, in order to determine IgE binding specificity. There
was substantial inhibition of IgE-FITC binding when
mixed with unlabelled IgE (p ≤0.05) but reduction in up-
take in the presence of IgG was not significant (Figure 2).
In further experiments, immature DCs (105) were
stained with IgE-FITC, in the presence or absence of
mannan, in order to exclude IgE binding via the
mannose receptor (i.e. through carbohydrates on IgE).
Der p 1 uptake with and without mannan was used to
show that mannan was active in the experiment. As
shown in Figure 3, whilst able to block Der p 1 uptake,
mannan had no effect on IgE binding to DCs.
*Figure 2 Inhibition of IgE-FITC binding by Mo-DCs. Immature
dendritic cells (105) were treated with IgE-FITC (7 μg/ml) plus blocking
IgE or IgG antibodies (20 μg/ml) for 20 minutes at 4°C and then
washed and fixed. Analysis was done by flow cytometry. The results
show a significant decrease in IgE-FITC binding when mixed with
unlabelled IgE, but not control IgG (*: p value ≤0.05). The data
presented represent the average of three independent experiments
expressed as mean ± SEM.
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structural integrity of the deglycosylated allergen
Der p 1 can be taken up efficiently by C-type lectin re-
ceptors (such as MR) on DCs via its sugar residues. To
study the influence of the uptake of Der p 1 through
immunoglobulins bound to DCs on T cell differentiation
without MR engagement, we deglycosylated Der p 1 to
exclude binding through MR. To confirm the deglycosyl-
ation of Der p 1, Western blotting of natural Der p 1
and deglycosylated Der p 1 against GNA (recognisesFigure 3 Effect of mannan on the binding of IgE-FITC. Immature
Mo-DCs (105) were treated with IgE-FITC (7 μg/ml) after pre-incubation
with and without mannan (200 μg/ml) for 20 minutes at 4°C, and then
washed and fixed. Analysis was done by flow cytometry. The data
presented represent the average of two independent experiments
expressed as mean ± SEM.terminal mannose 1–2, 1–3 and 1–6) was performed.
Unlike natural Der p 1, no band was visible with the
deglycosylated Der p 1 preparation (Figure 4). An ELISA
was used to ascertain the structural integrity of the
deglycosylated Der p 1. As shown in Figure 5, deglyco-
sylated Der p 1 was just as good as natural Der p 1 in
being recognised by the 2C7 and 5H8 antibodies
Der p 1 reactivity of IgE and IgG 2C7 antibodies
An ELISA was used to ascertain the Der p 1 reactivity of
the IgE and IgG 2C7 antibodies used in our experiments.
Results clearly indicate that the 2C7 antibodies react
specifically with Der p 1 and no such reactivity can be
demonstrated with the control allergen (Fel d 1) or the
isotypes control antibodies (Figure 5).
IgE receptors play an important role in Der p 1 uptake
by Mo-DCs
To investigate the role of IgE in the uptake of Der p 1
by Mo-DCs, we incubated Cy5 labelled Der p 1, with
and without IgE 2C7, with immature Mo-DCs at 37°C.
The experiment showed that adding IgE 2C7 signifi-
cantly increases Der p 1 uptake to a level over and above
that mediated by MR (Figure 6). The average means of
uptake of Der p 1-IgE 2C7 is significantly higher than
that of Der p 1 alone (p-value = 0.0051, n = 3), and Der pFigure 4 The effect of sodium periodate on Der p 1. Der p 1
was exposed to periodate for one hour and then immunoblotted
alongside natural Der p 1 (as a control) against the anti-mannose
sugar (GNA). The blot shows a very clear band with natural Der p 1,
while no band can be seen with the deglycosylated Der p 1.
Figure 5 ELISA results showing the reactivity of Der p 1 with monoclonal anti Der p 1 antibodies. Wells were coated with 5 μg/ml of
Der p 1 or a cat allergen (Fel d 1). IgE 2C7 (A) or IgG 2C7 (B) antibodies were used in different concentrations and binding detected using a goat
anti-human κ chain HRP-conjugated secondary antibody. The data presented represent the average of two (A) or three (B) independent
experiments expressed as mean ± SEM. In further experiments, wells were coated with 5 μg/ml of deglycosylated Der p 1 or Fel d 1. IgE 2C7
(C) or IgG 2C7 (D) antibodies were used in different concentrations and binding detected using a goat anti-human κ chain HRP-conjugated
secondary antibody. The data presented represent the average of two independent experiments expressed as mean ± SEM. Analysis by ELISA of the
binding of anti-Der p 1 5H8 antibody with periodate-treated Der p 1 (E) shows retention of Der p 1 protein structure. The data presented represent
the average of three independent experiments expressed as mean ± SEM.
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(p-value = 0.0036, n = 3). When the cells were pre-
treated with mannan, the means average of uptake of
Der p 1-IgE 2C7 was significantly higher than that of
Der p 1 (p-value = 0.0001, n = 3). In contrast, there was
no noticeable difference between the uptake of Der p 1
only (without treating cells with mannan) and Der p
1-IgE 2C7 (when treating cells with mannan) (Figure 6),
which clearly demonstrates that the MR- and specific
IgE-mediated pathways make approximately equalcontributions to Der p 1 uptake by Mo-DCs under
these conditions.FcεRI, FcεRII (CD23), FcγRI and MR expressions by
myeloid DCs
Myeloid DCs were stained with anti-FcεRIα PE, anti-
CD206 PC5, anti-CD23 ECD and anti-CD64 (FcγRI)
FITC. As shown in Figure 7, FcεRIα was expressed on
high proportion of myeloid DCs, whereas CD23 and MR
**
***
Figure 6 Uptake of Der p 1 by Mo-DCs is mediated by IgE
receptors. The median fluorescent index for the uptake of Der p 1
(0.26 μg/ml Cy5 labelled), with and without human IgE (10 μg/ml), IgE
2C7 (1 μg/ml) or 200 μg/ml mannan, by immature Mo-DCs at 37 .˚ **:
p ≤ 0.01; ***: p ≤ 0.001. The data presented represent the average of
three independent experiments expressed as mean ± SEM.
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on up to 43% of the myeloid DCs.
Role of IgE in inducing Th1/Th2 cytokine production in
myeloid DC-T cell co-cultures
Since myeloid (peripheral blood) DCs showed high level
of FcεRI and FcγRI (IgG high affinity receptor) expres-
sions, with only minimal expressions of CD23 and MR,
these cells provide an ideal opportunity to assess the role
of IgE and IgG-facilitated allergen presentation in T cell
polarisation with minimal or no interference by CD23
and MR.Figure 7 FcεRI, FcεRII, FcγRI and MR expressions on myeloid
DCs. Peripheral blood myeloid DCs were stained with various
monoclonal antibodies to detect FcεRI, CD23, FcγRI and MR. The
data presented are the average of four independent experiments
expressed as mean ± SEM.Myeloid DCs that had been loaded with natural or de-
glycosylated Der p 1, both with and without IgE and IgG
2C7 antibodies, were co-cultured with autologous naïve
T cells. IL-4, IL-5, IL-13 and IFN-γ secretions were then
detected using a FlowCytomix kit after stimulation with
PMA and Ionomycin.
The data demonstrated a high level of Th2 cytokine
(IL-4, IL-5 and IL-13) secretion when the IgE 2C7 anti-
body was used with either Der p 1 or deglycosylated Der
p 1, in comparison with using Der p 1 or deglycosylated
Der p 1 alone (Figure 8). However, the results were only
statistically significant for IL-4 (p ≤ 0.05) but not IL-5 or
IL-13. IFN-γ production was high in all these conditions.
As can be seen, deglycosylated Der p 1 gave rise to more
cytokine production in the presence of IgE 2C7 than gly-
cosylated Der p 1. This may have been due to deglyco-
sylated Der p1 being bound more efficiently by IgE 2C7.
Partial unmasking of the IgE 2C7 epitope could occur
upon removal of sugar residues if these sterically limiting
access by IgE 2C7. In further experiments, the IgE 2C7
antibody was compared to an isotype control (i.e. non-
specific human IgE) and again higher concentrations of
IL-4 and IL-13 cytokines were detected with IgE 2C7
(Figure 9). Importantly, no such effect was demonstrable
with the IgG 2C7 antibody (Figure 10). Collectively,
these data show the selectivity of IgE-facilitated Der p 1
uptake by DCs in terms of bias towards a Th2 pheno-
type. Whilst T cells in these co-cultures are most likely
sources of the detected cytokines, it worth highlighting
that measuring cytokines in the supernatant does not
allow exact identification of the cellular source of the
cytokines.
Discussion
It is well accepted that FcεRI is highly expressed on mast
cells and basophils. However, a noticeable feature of
FcεRI on APCs is that its expression is highly variable,
depending on the blood donor and the pathological situ-
ation [26]. We initially sought to monitor the kinetics of
the expression of the high and low affinity IgE receptors
(FcεRI and FcεRII [CD23], respectively), as well as the
high affinity IgG receptor (FcγRI, CD64), in relation to
MR during the generation of DCs from day zero (mono-
cytes) to day 6 (immature DCs) and then finally day 8
(mature DCs). We successfully detected the expression
of MR, FcεRI, FcεRII and FcγRI receptors on Mo-DCs as
a basis for exploring labelled-IgE binding to Mo-DCs.
The present study demonstrated a modest percentage
(43%) of FcεRI expression and high expression of CD23
(91%) and MR (98%) on immature Mo-DCs, in contrast
to FcγRI, which proved to be expressed in very low
levels.
IgE bound specifically to its receptors on immature
Mo-DCs, as its binding was inhibited by IgE but not by
*Figure 8 Th1 and Th2 cytokine responses to stimulated myeloid DCs, demonstrating the effect of Der p 1 taken up via IgE or IgG 2C7
uptake on naïve T cells polarisation. Myeloid DCs were pre-loaded with Der p 1 or deglycosylated Der p 1, both with and without IgE 2C7,
prior to establishing DC-naïve T cell co-cultures. T cells were re-stimulated at day 10 with PMA (15 ng/ml) and Ionomycin (1ug/ml). The following
conditions were used: cells only and Der p 1 or deglycosylated Der p 1, with and without IgE 2C7 (n = 3, except for deglycosylated Der p 1 only
condition which was done twice). The results were statistically significant for IL-4 when myeloid DCs were pre-loaded with Der p 1 and IgE 2C7
(*:p ≤ 0.05).
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vealed that the blocking effect of unlabelled IgE was only
demonstrable when added at the same time as labelled
IgE (i.e. in competition), and this could be due to the
rapid turnover of FcεRIα on the cell membrane.
DCs express the C-type lectin receptors MR and DC-
SIGN, which have the ability to recognise mannose
containing-carbohydrates on different antigens and patho-
gens. MR has specificity for proteins with mannose, fucose
and N-acetyl glucosamine, while DC-SIGN recognises high
mannose oligosaccharide structures [27,28]. Furthermore, it
has been shown that IgE is rich in mannose and N-acetyl
glucosamine oligosaccharides [29,30]. This, therefore, raises
the possibility of IgE binding to DCs via C-type lectinreceptors, particularly since previous studies have shown
that IgE can be taken up by human alveolar macrophages
via MR [31]. However, our data have shown that IgE bind-
ing by DCs is not mediated by C-type lectin receptors, as
its binding was not inhibited by mannan, the natural ligand
for MR and DC-SIGN.
The hypothesis that DCs could perform allergen cap-
ture and presentation via surface IgE is of great interest,
since this could lead to further perpetuation of allergic
tissue damage in atopic individuals where IgE circulates
in very high concentrations. We were uniquely placed to
test this hypothesis through the availability of IgE and
IgG chimaeric human 2C7 antibodies directed against
Der p 1, the major allergen of the HDM and an
Figure 9 Th1 and Th2 cytokine responses to stimulated myeloid DCs, demonstrating the effect of Der p 1 taken up via IgE 2C7, and
using non-specific human IgE antibodies as controls, on naïve T cell polarisation. Myeloid DCs were pre-loaded with Der p 1, with and
without IgE 2C7 antibody, prior to establishing DC-naïve T cell co-cultures. T cells were re-stimulated at day 10 with PMA (15 ng/ml) and Ionomycin
(1 ug/ml). The following conditions were used: cells only and Der p 1, with and without IgE 2C7 or IgE control (n =4). The data presented represent
the average of four independent experiments expressed as mean ± SEM.
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could study the role of IgE in allergen uptake on DCs
and compare it to IgG, particularly since these anti-
bodies have identical epitope specificity (i.e. same vari-
able domains) and differ only in their constant region
domains [24].
Having demonstrated IgE binding to its receptors
(FcεRI and FcεRII) on DCs, we proceeded to investigate
the role of IgE in Der p 1 uptake using a flow cytometry
approach, whereby DCs were loaded with labelled Der p
1-IgE 2C7 complexes. Since Der p 1 can be internalisedby MR and DC-SIGN [12,13,32], we used mannan, a
polymer of mannose, to block MR and DC-SIGN in
order to distinguish Der p 1 binding via IgE from that
via C-type lectins. The results obtained show that Der p
1 uptake by DCs increases in the presence of IgE 2C7,
but not when human IgE of irrelevant specificity was
used as a control. Mannan significantly inhibited Der p 1
uptake by Mo-DCs when DCs were loaded with Der p 1
alone, but not when cells were loaded with Der p 1-IgE
2C7 complexes. This provides direct evidence that Der
p 1 uptake by Mo-DCs is also mediated by a separate
Figure 10 Th1 and Th2 cytokine responses to stimulated myeloid DCs, demonstrating the effect of Der p 1 taken up via IgG 2C7, and
using non-specific human IgG antibodies as controls, on naïve T cell polarisation. Myeloid DCs were pre-loaded with Der p 1 or deglycosylated
Der p 1, both with and without IgG 2C7 antibody, prior to establishing DC-naïve T cell co-cultures. T cells were re-stimulated at day 10 with
PMA (15 ng/ml) and Ionomycin (1ug/ml). The following conditions were used: cells only, Der p 1 or deglycosylated Der p 1, with and without
IgG 2C7 (n = 4 and n = 5, respectively), and Der p 1 or deglycosylated Der p 1, with IgG controls (n =3). The results were statistically significant
for IFN-γ when myeloid DCs were pre-loaded with Der p 1 and IgG 2C7 (*:p ≤ 0.05).
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receptors.
The ultimate goal of this study was to explore the role
of IgE in allergen uptake and its presentation by DCs via
IgE receptors particularly FcεRI, and to compare this
with IgG. In line with previous studies [33,34], we found
that myeloid DCs have very low expression of CD23,
MR and DC-SIGN, but high expression of FcεRI and
FcγRI and are therefore ideally suited for our study.
Because MR and DC-SIGN internalise Der p 1 via
their carbohydrate binding specificity, we further useddeglycosylated Der p 1 to explore the role of IgE in the
uptake of Der p 1 without interference from any residual
C-type lectins. The deglycosylated Der p 1 protein used
reacted with the anti-Der p 1 5H8 antibody, as well as
with 2C7 antibodies, thereby confirming its structural
integrity.
It is well understood that the activation of CD4+
T cells leads their differentiation towards one of few de-
velopmental pathways such as Th1, Th2, Th17 or Treg
depending on the concentration of different cytokines in
the microenvironment amongst other factors [35,36].
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abundant in allergic disease, and these cytokines play a
central role in initiating allergic inflammation. Thus, we
investigated the effect of IgE and IgG-facilitated Der p 1
uptake by peripheral blood myeloid DCs on downstream
events at the T cell level.
The co-culture experiments showed that IgE facilitated
Der p 1 uptake by myeloid DCs supported the differenti-
ation of naïve T cells towards a Th2 cell phenotype.
Given the low expression of CD23 on myeloid DCs this
effect is most likely mediated via FcεRI however we can-
not rule out possible up-regulation of CD23 after sensi-
tisation with IgE antibody hence a contribution from
CD23 remains a possibility. The Th2 bias was evidenced
by high levels of Th2 cytokine secretion, particularly IL-
4, when the IgE 2C7 antibody was used in combination
with natural Der p 1 or deglycosylated Der p 1. However,
these findings did not reach statistical significance with
two (i.e. IL-5 and IL-13) of the three Th2 cytokines
tested most likely due to the low number of donors and
wide inter donor variations obtained. Previous analysis
of 55 crystal structures of known allergens (including
Der p 1) has shown that dimerisation is a very common
and essential feature of allergens [37]. We can therefore
reasonably assume that although we were using a mono-
clonal IgE antibody (i.e. 2C7), which will not permit
cross-linking by Der p 1 monomers, the biological
effects observed in our DC-bound IgE/Der p 1 uptake
experiments were due to IgE cross linking by Der p 1
dimers. However, given the importance of polyvalent
cross-linking in efficient internalisation of FcεRI-bound
IgE [18] it is reasonable to expect that using a polyclonal
anti Der p 1 IgE antibody could further enhance the
observed biological effects such as Th2 cell polarisation.
Interestingly, and as expected, we were unable to show a
similar bias towards Th2 differentiation when using the
IgG 2C7 antibody.
Our results are in keeping with a recent study by
Sallmann and co-workers using a new transgenic mouse
model, which suggested that FcεRI expressed by DCs
does indeed play a role in antigen uptake and the devel-
opment of Th2 allergic tissue inflammation [38].
In conclusion, IgE could play an important role in Der
p 1 uptake and processing by peripheral blood myeloid
DCs and in the Th2 polarisation of T cells. This would
clearly serve to perpetuate symptoms of allergy in atopic
patients where IgE is already produced in large quan-
tities. It is known that DCs prime Th2 cell polarisation
after encountering allergens, but the particular mechan-
ism by which DCs induce Th2, instead of Th1, develop-
ment is not fully understood. The present work provides
a potential mechanism by which myeloid DCs may
support the development of Th2 responses and suggests
a novel target for therapy.Conclusions
Whist C-type lectins play a key role in recognition and
uptake of glyco-allergens including Der p 1, this study
shows that IgE bound to its high affinity receptor plays
an important role in the uptake and processing of Der p 1
by peripheral blood DCs as well as in Th2 polarisation
of T cells. Such IgE mediated pathway of allergens
uptake could be particularly important in individuals
with high serum IgE levels who have already been
sensitised to an allergen.
Methods
Der p 1 preparations
Der p 1 was purchased from Indoor Biotechnologies
(Warminster, UK) and labelled with Cyanine 5 (Cy5) using
a Cy5 labelling kit (GE Healthcare, Buckinghamshire, UK)
according to the manufacturer’s instructions. The concen-
tration of labelled allergens was determined by NanoDrop
prior to use.
In order to deglycosylate natural Der p 1, sodium
metaperiodate (Sigma-Aldrich, Irvine, UK) was used as
previously described [39]. Briefly, Der p 1 was treated at
a molar ratio of 5:1 with sodium periodate. Following
incubation for one hour at room temperature in the
dark, the oxidation process was stopped by adding
0.25 ml of ethylene glycol per ml of the reaction mixture.
The deglycosylated samples were then dialysed at room
temperature.
Deglycosylation was then confirmed using Western
blot analysis. Briefly, using 12% Tris-Glycine precast gels
(Invitrogen, Paisley, UK), gel electrophoresis was per-
formed for 5 μg of natural and deglycosylated Der p 1
proteins, and these proteins were then transmitted to
nitrocellulose membranes (GE Healthcare Life Sciences,
Buckinghamshire, UK). Next, a DIG Glycan Differenti-
ation kit (Roche Applied Science, Burgess Hill, UK) was
used to determine the glycan content following the
manufacturer’s instructions.
The structural integrity of the deglycosylated Der p 1
preparation was also tested against 2C7 and biotinylated
5H8 anti-Der p 1 antibodies, clone 5H8 C12, (Indoors
Biotechnologies), using standard ELISA procedure in which
the binding was detected using Extra Avidin alkaline
phosphatase conjugate (Sigma-Aldrich, Irvine, UK).
Generation of dendritic cells
Peripheral blood samples from non-atopic donors
(obtained following local ethics committee approval and
after obtaining informed consent) were used for separ-
ation of peripheral blood mononuclear cells (PBMCs) by
density gradient centrifugation on Histopaque-1077
(Sigma-Aldrich, Irvine, UK). PBMCs were then incu-
bated with mouse anti-human CD14 monoclonal anti-
body (mAb) conjugated to magnetic beads (Miltenyi
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lected using a magnetic cell separation system (Miltenyi
Biotec, Bisley, UK).
Immature DCs were generated from CD14+ mono-
cytes by culturing them with 50 ng/ml of Granulocyte-
Macrophage colony stimulating factor (GM-CSF) and
250 IU/ml of IL-4 (both from R & D system, UK) in
RPMI-1640 medium, supplemented with L-glutamine,
penicillin and streptomycin (Sigma-Aldrich, Irvine, UK),
and 10% FBS (Autogen Bioclear, Wiltshire, UK) (1 × 106
cells/ml) in a 24-well flat bottom culture plate (Costar,
High Wycombe, UK) at 37°C in 5% CO2 for six days as
we have previously described [13,40,41]. The maturation of
monocyte-derived DCs (Mo-DCs) was achieved by adding
lipopolysaccharide (LPS) (200 ng/ml) (Sigma-Aldrich,
Irvine, UK) to the immature DCs on day six and then
incubating them for 48 hours at 37°C in a humidified
atmosphere of 5% CO2.
In other experiments, where peripheral blood myeloid
DCs (mDCs) (CD1c, BDCA-1) were used, these cells
were separated from PBMCs by two magnetic separation
steps using the CD1c (BDCA-1) + dendritic cell isolation
kit from Miltenyi Biotech (Bisley, UK) and following the
manufacturer’s guidelines. Briefly, CD1+C cells were
purified by positive selection after depletion of PBMCs
of CD19+B cells as previously described [34].
The expression of IgE, IgG and mannose receptors by
dendritic cells
The expression of FcεRI, FcεRII (CD23), FcγRI (CD64)
and the mannose receptor was determined during the
course of generating DCs, starting from day zero (mono-
cyte) through to days 2, 4, 6 (immature) and 8 (mature).
Receptor expression was also demonstrated on periph-
eral blood myeloid DCs (mDCs).
Following the isolation of monocytes from PBMCs and
culturing them for DC generation, Mo-DCs (or mDCs
were applicable) were harvested on each day of cell cul-
ture, washed with phosphate-buffered albumin (PBA;
consisting of phosphate buffer saline, 0.5% bovine serum
albumin and 0.1% sodium azide) and stained with anti-
CD206 PC5, clone 19.2 (Pharmingen, San Diego, CA,
USA), anti-CD23 ECD, clone 9P25, anti-CD64 (FcγRI)
FITC, clone 22 (Beckman Coulter, High Wycombe, UK)
and anti-FcεRIα PE clone AER-37(CRA-1) (Cambridge
Biosceince, Cambridge, UK) for 25 minutes in the dark
at 4°C. The cells were then washed with PBA and fixed
with 0.5% formaldehyde. Isotype control antibodies were
used to determine binding specificity. Samples were ana-
lysed using flow cytometry as described before [42]. A
minimum of 10,000 events were collected for each sam-
ple on a Beckman coulter FC500 flow cytometer. Data
were analysed using WinMDI version 2.9. Cell popula-
tions of interest were initially gated on using forwardand side scatter characteristics. For each sample the
quadrants were typically set such that < 0.5% were posi-
tive in isotype control samples.
IgE binding to Mo-DCs
Purified human IgE (Abbiotec, York, UK) was labelled with
fluorescein using a Fluoro-Trap™ fluorescein labelling kit
(Innova Biosciences Ltd, Cambridge, UK) according to the
manufacturer’s instructions. The concentration of labelled
IgE was determined by NanoDrop prior to use. In the assay
for inhibition of labelled IgE uptake by DCs, unlabelled
human IgE and IgG were used at different concentrations
(Sigma-Aldrich, Irvine, UK) to stain 105 immature Mo-
DCs, which were first washed with PBA and tested as
follows:
Three sets of DCs were prepared (105 each). The first
set was stained with IgE-FITC (7 μg/ml), the second set
treated with unlabelled IgE (20 μg/ml) plus IgE-FITC
(7 μg/ml) and the third set treated with IgG (20 μg/ml)
plus IgE-FITC (7 μg/ml). Later, the cells were incubated
for 20 minutes at 4°C and then washed with PBA and
fixed. The detection of labelled IgE binding was per-
formed using flow cytometry.
IgE binding to Mo-DCs in the presence and absence
of mannan
Four sets of DCs were prepared (105 each). The first set
was stained with IgE-FITC (7 μg/ml), the second set
treated with 200 μg/ml mannan (MR ligand used as
inhibitor) (Sigma-Aldrich, Irvine, UK) for 20 minutes
at 37°C, washed and mixed with IgE-FITC (7 μg/ml),
the third set incubated with Cy5-labeled Der p 1 for
20 minutes, while the fourth set was treated with
200 μg/ml mannan for 20 minutes at 37°C then washed
and loaded with Cy5-Der p 1 for 20 minutes at 4°C
followed by washing with PBA and fixing. The detection
of labelled IgE and Der p 1 binding was performed using
flow cytometry.
Investigating the Der p 1 binding capacity of IgE and
IgG1 2C7 antibodies by ELISA
The Der p 1 reactivity of IgE and IgG1 2C7 antibodies was
investigated by ELISA. Maxisorp 96-well microtiter plates
(Nunc, Roskilde, Denmark) were coated with Der p 1 (or
deglycosylated Der p 1 (deg) where applicable) or the con-
trol allergen Fel d 1 (major allergen from the domestic cat
Felis domisticus) (5 μg/ml) (Indoor Biotechnologies,
Warminster, UK). The plates were incubated overnight at
4°C then washed three times using PBS-0.05% Tween-20
before blocking with PBS −1% BSA buffer for one hour at
room temperature.
The coated plates were then washed and 2C7 anti-
bodies, along with human IgE (Abbiotec, York, UK) and
IgG (Sigma-Aldrich, Irvine, UK) control antibodies were
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hours. Subsequently, the plates were washed three times
and the binding was detected by incubation with a goat
anti-human κ chain HRP-conjugated secondary antibody
(Sigma-Aldrich, Irvine, UK). After three washes with
PBS-Tween, followed by a single wash with a proprietary
HRP substrate buffer (24 mM citric acid and 52 mM
Na2HPO4 in ddH20, pH 5.2), the plates were subse-
quently developed with o-Phenylenediamine (OPD)
(Sigma-Aldrich, Irvine, UK) in a HRP substrate buffer
containing 0.012% H2O2. The absorbance was measured
at 492 nm.
Testing the specificity of IgE-facilitated Der p 1 uptake by
Mo-DCs
Mannan (200 μg/ml), MR’s natural ligand, was added to
aliquots of Mo-DCs using uptake media containing
RPMI (Sigma-Aldrich, Irvine, UK), 30% PBS with Ca+2
and Mg+2 (Gibco- Invitrogen, Paisley, UK) and 10% FBS
(Autogen Bioclear, Wiltshire, UK). The cells were then
incubated for 20 minutes at 37°C.
Different mixtures of Cy5-Der p 1 with or without
human IgE or IgE 2C7 were prepared and incubated at
37°C for 20 minutes. These mixtures were added to cells
that had either been pre-incubated with mannan or not,
and then incubated for 20 minutes at 37°C. The final
concentration of Der p 1 was 0.26 μg/ml, while human
IgE and IgE 2C7 were used at 1 μg/ml. The cells were
then washed and fixed with 0.5% formaldehyde.
In parallel, other cell aliquots were treated with 1 μg/
ml or 10 μg/ml human IgE for 20 minutes at 4°C in
order to block IgE receptors, following which they were
washed and loaded with the mixture of Der p 1-IgE 2C7
as above for 20 minutes. The quantitative Cy5-Der p 1
uptake was then established using flow cytometry.
Myeloid DC-T cell co-culture
Myeloid dendritic cells were incubated with Der p 1 or
deg Der p 1 (0.26 μg/ml), with and without IgE 2C7, IgG
2C7, IgE or IgG (1 μg/ml), for two to three hours at
37˚C. Cells were then washed and cultured with autolo-
gous CD3 + CD45RO- (naïve) T cells at DC/T cell ratio
of 1:5. The naïve T cells had been negatively separated
from PBMCs, using a magnetic cell separation system
(Miltenyi Biotec, Bisley, UK) and following the manufac-
turer’s instructions.
Cultures were carried out using 96-well U bottom
plates (Nunc, Roskilde, Denmark) and RPMI 1640 sup-
plemented with penicillin/streptomycin (Sigma-Aldrich,
Irvine, UK) and 10% human AB serum (Sigma-Aldrich,
Irvine, UK). IL-2 (20 IU, ml) (R & D system) was added
every three to four days until day 10 of culture. After
10 days of culture, T cells were re-stimulated overnight
with PMA (15 ng/ml) and Ionomycin (1 μg/ml). Thesupernatant from each condition was collected, and
FlowCytomix Human Basic kits were used in order to
detect cytokine concentrations.
Statistical analysis
Student’s T test and Mann–Whitney test were used to
perform the statistical analysis. Data was considered
statistically significant when P-values were less than
0.05. *: p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001.
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